The majority of the patients were identified as having mutations in BRAF-V600E and were most predominant in thyroid carcinoma, colon cancer, and skin cancer (Tufano et al., 2012) (Lasota et al., 2014) (Ascierto et al., 2012). This evidence concerns the gene BRAF and malignant colon neoplasm.